FiercePharma: Leqembi launch hamstrung by physicians' 'therapeutic nihilism'



Dr. M****** G*******, a professor at Stanford University's Center for Memory Disorders, said there is little evidence that Leqembi benefits patients in a meaningful way.
 
Dr. M****** G*******, a professor at Stanford University's Center for Memory Disorders, said there is little evidence that Leqembi benefits patients in a meaningful way.

“If we take the trial result at face value, the differences between placebo and treatment are likely small enough as to be undetectable by patients and family members or physicians,” Michael Greicius, M.D., a professor at Stanford University's Center for Memory Disorders, said. Greicius doesn’t recommend Leqembi to patients.
 


Write your reply...